1. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation;Moncada, S.; Gryglewski, R.J.; Bunting, S.; Vane, J.R.;Nature,1976
2. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin;Szczeklik, A.; Nizankowski, R.; Skawinski, S.; Szczeklik, G.; Gluszko, P.; Gryglewski, R.J.;Lancet,1979
3. Conservative treatment of inoperable arterial occlusions of the lower extremities with intraarterial prostaglandin E;Gruss, J.D.; Bartels, D.; Ohta, T.; Machato, J.L.; Schlechtwey, G.;Br J Surg,1982
4. Discovery, biological significance and therapeutic potential of prostacyclin;Moncada, S.; Vane, J.R.,1981
5. Clinical pharmacology and potential ofprostacyclin;Lewis, P.J.; Dollery, C.T.;Br MedBull